Mortara Instrument Inc. (U.S.), Spacelabs Healthcare (U.S), Schiller AG (Switzerland), Cardionet (U.S.), Compumed Inc. (U.S.), Nihon Kohden Corporation (Japan), and Welch Allyn (U.S.)
(PRWEB) October 18, 2014
The “Global Diagnostic Electrocardiograph (ECG) Market by Product (Resting, Stress, Holter Monitor), by End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing Homes), by Lead Type (Single, 3-6, 12) -Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global diagnostic ECG market along with the estimates and forecasts of the revenue and share analysis.
The global diagnostic ECG market will reach $5,435 million by 2020 growing at a CAGR of 5.7% during the forecast period (2013–2020).
For Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=173
The global diagnostic ECG market in the resting system segment had the largest share of the total diagnostic ECG market in 2013 and will continue to grow in the next five years to retain the leading position by 2020. The high growth in holter monitor segment is attributed to the low costs and space efficiency. Factors such as technological advancements in communication, low power circuit design for better and safer ECG devices, portable features with lower power consumption, more accuracy and capacity to incorporate the latest diagnostic features are driving the diagnostic ECG market.
North America accounted for the largest market share in the diagnostic ECG market, whereas the APAC region is expected to register the highest growth rate due to its enormous growth opportunities and manufacturing cost benefits. The large patient base and increasing income levels are also expected to propel the growth of this market. The diagnostic ECG devices are increasingly being networked across various hospitals. Most of the larger hospitals are preferring computerization for maintaining electrocardiogram records and investing steadily in data management systems to allow physicians to access the comparative analysis of the patients’ overall data. The advanced technologies such as the wireless technologies also provide growth opportunities.
Moreover, the rising incidences of cardiac diseases and diseases such as diabetes and hypertension have also contributed to the growth of the diagnostic ECG market. The resting ECG devices segment had the largest share, while the holter monitor systems market was the fastest growing segment in 2013. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the resting ECG devices segment. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients’ health and status.
Get PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=173
The grey area while estimating the market was the overlapping nature of the implantable cardioverter-defibrillator (ICDs) and devices used in event monitoring while segregating them based on the evaluation of endpoints involved, as there is a thin line between diagnostic and monitoring devices. This was later clarified with the help of various experts that participated during the study.
From an insight perspective, this research report focuses on the qualitative data, market size, share, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It also focuses on the emerging and high-growth segments of the diagnostic ECG market.
The competitive landscape covers the growth strategies adopted by the industry players in the last three years. The company profiles comprise the basic views on the key players in the ECG market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market share in the near future.
The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
GE Healthcare was the leader in the diagnostic ECG market in 2013. GE also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Philips Healthcare distantly followed GE in the diagnostic ECG market in 2013. The other major players in the market are Mindray Medical (China), Mortara Instrument Inc. (U.S.), Spacelabs Healthcare (U.S), Schiller AG (Switzerland), Cardionet (U.S.), Compumed Inc. (U.S.), Nihon Kohden Corporation (Japan), and Welch Allyn (U.S.).
Browse Related Reports:
Companion Diagnostics Market byTechnology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets